Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer
Trial Number
2018-001072-37 (EudraCT Number)Contact Person
Status
Closed to Recruitment
Disease Site
Endometrial
Lead Cooperative Group
Participating Groups
GEICO
SAKK
AGO-AUST
NCRI
AGO
JGOG
ANZGOG